Adriana Blancafort

403 citations
9 papers · 331 indexed · h-index 7
Topics
Cancer, Lipids, and Metabolism (6 papers)Peroxisome Proliferator-Activated Receptors (5 papers)HER2/EGFR in Cancer Research (2 papers)
Partner nations
SpainUnited States

In The Last Decade

Adriana Blancafort

9 papers receiving 326 citations

Peers

Adriana Blancafort
Comparison fields: 5 of 53
  • Molecular Biology 234
  • Cancer Research 221
  • Oncology 54
  • Pathology and Forensic Medicine 29
  • Pulmonary and Respiratory Medicine 25
Replace R.A. Assal with:
R.A. Assal Egypt
Tiemin Pei China
Nidula Mullappilly Italy
Leilei Li China
Wence Zhou China
Jia Shusheng China
Suxia Luo China
Jianping Chen China
Xiangjie Huang China
Nichelle C. Whitlock United States
Adriana Blancafort relative to R.A. Assal Egypt R.A. Assal's profile →
Citations per field
00.5×4.3×
R.A. Assal · 1×
Citations per year

Countries citing papers authored by Adriana Blancafort

Since Specialization
Citations

This map shows the geographic impact of Adriana Blancafort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Blancafort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Blancafort more than expected).

Fields of papers citing papers by Adriana Blancafort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Blancafort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Blancafort. The network helps show where Adriana Blancafort may publish in the future.

Co-authorship network of co-authors of Adriana Blancafort

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Blancafort. A scholar is included among the top collaborators of Adriana Blancafort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Blancafort. Adriana Blancafort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 1
2 76
3 54
4 13
5 86
6 58
7 3
8 13
9 27

About Adriana Blancafort

Adriana Blancafort is a scholar working on Cancer Research, Microbiology and Pharmacology, having authored 9 papers that have together received 331 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (221 citations), Applied Microbiology and Biotechnology (10 citations) and Molecular Biology (234 citations). Adriana Blancafort has collaborated with scholars based in Spain and United States. Frequent co-authors include Teresa Puig, Glòria Oliveras, Joana Relat, Pedro F. Marrero, Diego Haro, Sònia Palomeras, Ariadna Giró‐Perafita, Sílvia Cufí, Gemma Viñas and David H. Lum. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026